Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Encouraging news today from MGC related to eliminating Glioblastoma cells and the research paper published by MDPI.
In summary:
* The research paper tests Cannabidiol (CBD) and Cannabigerol (CBG) extracts provided by MGC Pharmaceuticals and their impact on Glioblastoma cells. The study finds that GPR55 and TRPV1 receptors are the best targets for the antagonistic cannabinoids CBD and CBG (in an optimised mixture) to eliminate Glioblastoma (GBM) stem cells.
Another step in the right direction.
Good luck, Brighty
Slowly slowly catchy something. Is a step in the right direction and one day could be a wonder cure, shame the sp will not until then.
I sold in Feb at £0.0148 taking a £6.5k loss, I knew it was a lost cause long before and should have sold earlier, but kept thinking 'jam tomorrow'.
Just checking back to see if I made the right decision, and I have no doubts.
The posts on here remain much the same, although most of the names have changed.
It was a good learning experience, despite dabbling in the markets for nearly 30 years one never stops learning, and when one decides to take a hit its reassuring to know the right decision was made.
I wish you all luck.
US delivery of 1000,000 Artemic C. US requiring more!
Yes, more encouraging news and excellent messaging from MGC:
* "US$1,000,000 order owing to increasing demand"
* "MGC Pharma's largest delivery into the US market to date".
Bodes well. Good luck, Brighty
I didn't read where it required more .??? It only for filled an order they all ready had . When they get new orders then that will be good news
I nearly did what you did but I’m pretty sure this will grow nicely over the next few years …I’m holding for GOLD